< Back to latest news & events

Event

Medical Technology Ireland – Galway Racecourse

September 2019

Event date: 26th September 2019

HGF Partners Kieran Killough and Craig Thomson will be discussing preparation for IP Due Diligence at Medical Technology Ireland on 26th September.

Medical Technology Ireland 2019 will bring together leading international medical device experts providing insight on cutting edge topics for medical device manufacturers, R&D and design engineers in the rapidly evolving Irish and global device marketplace. The conference will define present and future medical device trends, investigate, discuss and improve the quality of life for patients worldwide.

Kieran Killough and Craig Thomson are presenting “preparing for IP Due Diligence: Using your IP to get investment” on Wednesday 26th September. They will discuss how chances of investment are optimised if companies can effectively demonstrate to investors that their IP adequately underpins the business plan on which the investment pitch is based. They will address the following:

  • What is IP Due Diligence?
  • What are the mistakes commonly made during this process?
  • How do you ensure that you impress investors?
  • The importance of demonstrating a relevant IP strategy and timeline that integrates well with your business plan, including your clinical development plan.

Attendees

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article